{"id":2010,"date":"2012-11-30T16:40:33","date_gmt":"2012-11-30T15:40:33","guid":{"rendered":"http:\/\/blogs.funiber.org\/pt\/?p=2010"},"modified":"2012-12-04T16:48:55","modified_gmt":"2012-12-04T15:48:55","slug":"sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes","status":"publish","type":"post","link":"https:\/\/www.funiber.blog\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes","title":{"rendered":"SP ir\u00e1 produzir medicamentos contra rejei\u00e7\u00e3o de transplantes"},"content":{"rendered":"<p><a href=\"http:\/\/blogs.funiber.org\/nutricao\/files\/2012\/12\/medicostransplante_120927_minsaude_cc.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-1223\" src=\"http:\/\/blogs.funiber.org\/nutricao\/files\/2012\/12\/medicostransplante_120927_minsaude_cc.jpg\" alt=\"\" width=\"300\" height=\"200\" \/><\/a>Nos dias de hoje, dois dos medicamentos mais utilizados para evitar a rejei\u00e7\u00e3o de rins e cora\u00e7\u00e3o transplantados s\u00e3o importados. Os medicamentos <em>micofenolato de s\u00f3dio<\/em> e o <em>everolimo<\/em> do laborat\u00f3rio Novartis, s\u00e3o importado da Su\u00ed\u00e7a. Ambos os medicamentos s\u00e3o largamente utilizados, no Brasil, para evitar a rejei\u00e7\u00e3o de rins e cora\u00e7\u00e3o transplantados, com custo elevado tanto para o governo, quanto para os pacientes.<!--more--><\/p>\n<p>Para enfrentar essa situa\u00e7\u00e3o a FURP (Funda\u00e7\u00e3o para o Rem\u00e9dio Popular), laborat\u00f3rio farmac\u00eautico oficial do governo do Estado de S\u00e3o Paulo, fechou um acordo de transfer\u00eancia de tecnologia para produzir esses medicamentos que ter\u00e1 distribui\u00e7\u00e3o gratuitamente pelo SUS. (Sistema \u00danico de Sa\u00fade).<\/p>\n<p>Essa transfer\u00eancia de tecnologia do laborat\u00f3rio Novartis para a FURP deve beneficiar 28 mil pacientes brasileiros.<\/p>\n<p><a href=\"http:\/\/noticias.r7.com\/saude\/sp-vai-produzir-dois-remedios-contra-rejeicao-de-transplantes-para-distribuicao-no-sus-03122012\">http:\/\/noticias.r7.com\/saude\/sp-vai-produzir-dois-remedios-contra-rejeicao-de-transplantes-para-distribuicao-no-sus-03122012<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nos dias de hoje, dois dos medicamentos mais utilizados para evitar a rejei\u00e7\u00e3o de rins e cora\u00e7\u00e3o transplantados s\u00e3o importados. Os medicamentos micofenolato de s\u00f3dio e o everolimo do laborat\u00f3rio Novartis, s\u00e3o importado da Su\u00ed\u00e7a. Ambos os medicamentos s\u00e3o largamente utilizados, no Brasil, para evitar a rejei\u00e7\u00e3o de rins e cora\u00e7\u00e3o transplantados, com custo elevado [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_newsletter_tier_id":0,"footnotes":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false}}},"categories":[3],"tags":[],"jetpack_publicize_connections":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SP ir\u00e1 produzir medicamentos contra rejei\u00e7\u00e3o de transplantes - FuniBlogs - FUNIBER<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SP ir\u00e1 produzir medicamentos contra rejei\u00e7\u00e3o de transplantes - FuniBlogs - FUNIBER\" \/>\n<meta property=\"og:description\" content=\"Nos dias de hoje, dois dos medicamentos mais utilizados para evitar a rejei\u00e7\u00e3o de rins e cora\u00e7\u00e3o transplantados s\u00e3o importados. Os medicamentos micofenolato de s\u00f3dio e o everolimo do laborat\u00f3rio Novartis, s\u00e3o importado da Su\u00ed\u00e7a. Ambos os medicamentos s\u00e3o largamente utilizados, no Brasil, para evitar a rejei\u00e7\u00e3o de rins e cora\u00e7\u00e3o transplantados, com custo elevado [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes\" \/>\n<meta property=\"og:site_name\" content=\"FuniBlogs - FUNIBER\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/funiber\" \/>\n<meta property=\"article:published_time\" content=\"2012-11-30T15:40:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2012-12-04T15:48:55+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/blogs.funiber.org\/nutricao\/files\/2012\/12\/medicostransplante_120927_minsaude_cc.jpg\" \/>\n<meta name=\"author\" content=\"Administrador Blogs CT\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FUNIBER\" \/>\n<meta name=\"twitter:site\" content=\"@FUNIBER\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Administrador Blogs CT\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes#article\",\"isPartOf\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes\"},\"author\":{\"name\":\"Administrador Blogs CT\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/0eae3cfb523a46b015366e49f7c79e8f\"},\"headline\":\"SP ir\u00e1 produzir medicamentos contra rejei\u00e7\u00e3o de transplantes\",\"datePublished\":\"2012-11-30T15:40:33+00:00\",\"dateModified\":\"2012-12-04T15:48:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes\"},\"wordCount\":156,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#organization\"},\"articleSection\":[\"Sa\u00fade e Nutri\u00e7\u00e3o\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes\",\"url\":\"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes\",\"name\":\"SP ir\u00e1 produzir medicamentos contra rejei\u00e7\u00e3o de transplantes - FuniBlogs - FUNIBER\",\"isPartOf\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#website\"},\"datePublished\":\"2012-11-30T15:40:33+00:00\",\"dateModified\":\"2012-12-04T15:48:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/blogs.funiber.org\/pt\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SP ir\u00e1 produzir medicamentos contra rejei\u00e7\u00e3o de transplantes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#website\",\"url\":\"https:\/\/blogs.funiber.org\/pt\/\",\"name\":\"FuniBlogs - FUNIBER\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blogs.funiber.org\/pt\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#organization\",\"name\":\"FuniBlogs - FUNIBER\",\"url\":\"https:\/\/blogs.funiber.org\/pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.funiber.blog\/pt\/wp-content\/uploads\/2022\/02\/logo-funiber-pt-br-v-dos.svg\",\"contentUrl\":\"https:\/\/www.funiber.blog\/pt\/wp-content\/uploads\/2022\/02\/logo-funiber-pt-br-v-dos.svg\",\"width\":1,\"height\":1,\"caption\":\"FuniBlogs - FUNIBER\"},\"image\":{\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/funiber\",\"https:\/\/twitter.com\/FUNIBER\",\"https:\/\/www.instagram.com\/funiber_becas\",\"https:\/\/www.youtube.com\/user\/funiber\",\"https:\/\/www.linkedin.com\/company\/funiber\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/0eae3cfb523a46b015366e49f7c79e8f\",\"name\":\"Administrador Blogs CT\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/097db6469009a1dba4db4c0390a1e929?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/097db6469009a1dba4db4c0390a1e929?s=96&d=mm&r=g\",\"caption\":\"Administrador Blogs CT\"},\"url\":\"https:\/\/www.funiber.blog\/pt\/author\/ct-admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SP ir\u00e1 produzir medicamentos contra rejei\u00e7\u00e3o de transplantes - FuniBlogs - FUNIBER","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes","og_locale":"pt_BR","og_type":"article","og_title":"SP ir\u00e1 produzir medicamentos contra rejei\u00e7\u00e3o de transplantes - FuniBlogs - FUNIBER","og_description":"Nos dias de hoje, dois dos medicamentos mais utilizados para evitar a rejei\u00e7\u00e3o de rins e cora\u00e7\u00e3o transplantados s\u00e3o importados. Os medicamentos micofenolato de s\u00f3dio e o everolimo do laborat\u00f3rio Novartis, s\u00e3o importado da Su\u00ed\u00e7a. Ambos os medicamentos s\u00e3o largamente utilizados, no Brasil, para evitar a rejei\u00e7\u00e3o de rins e cora\u00e7\u00e3o transplantados, com custo elevado [&hellip;]","og_url":"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes","og_site_name":"FuniBlogs - FUNIBER","article_publisher":"https:\/\/www.facebook.com\/funiber","article_published_time":"2012-11-30T15:40:33+00:00","article_modified_time":"2012-12-04T15:48:55+00:00","og_image":[{"url":"http:\/\/blogs.funiber.org\/nutricao\/files\/2012\/12\/medicostransplante_120927_minsaude_cc.jpg"}],"author":"Administrador Blogs CT","twitter_card":"summary_large_image","twitter_creator":"@FUNIBER","twitter_site":"@FUNIBER","twitter_misc":{"Escrito por":"Administrador Blogs CT","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes#article","isPartOf":{"@id":"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes"},"author":{"name":"Administrador Blogs CT","@id":"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/0eae3cfb523a46b015366e49f7c79e8f"},"headline":"SP ir\u00e1 produzir medicamentos contra rejei\u00e7\u00e3o de transplantes","datePublished":"2012-11-30T15:40:33+00:00","dateModified":"2012-12-04T15:48:55+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes"},"wordCount":156,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.funiber.org\/pt\/#organization"},"articleSection":["Sa\u00fade e Nutri\u00e7\u00e3o"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes","url":"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes","name":"SP ir\u00e1 produzir medicamentos contra rejei\u00e7\u00e3o de transplantes - FuniBlogs - FUNIBER","isPartOf":{"@id":"https:\/\/blogs.funiber.org\/pt\/#website"},"datePublished":"2012-11-30T15:40:33+00:00","dateModified":"2012-12-04T15:48:55+00:00","breadcrumb":{"@id":"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.funiber.org\/pt\/saude-e-nutricao\/2012\/11\/30\/sp-ira-produzir-medicamentos-contra-rejeicao-de-transplantes#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/blogs.funiber.org\/pt"},{"@type":"ListItem","position":2,"name":"SP ir\u00e1 produzir medicamentos contra rejei\u00e7\u00e3o de transplantes"}]},{"@type":"WebSite","@id":"https:\/\/blogs.funiber.org\/pt\/#website","url":"https:\/\/blogs.funiber.org\/pt\/","name":"FuniBlogs - FUNIBER","description":"","publisher":{"@id":"https:\/\/blogs.funiber.org\/pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.funiber.org\/pt\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/blogs.funiber.org\/pt\/#organization","name":"FuniBlogs - FUNIBER","url":"https:\/\/blogs.funiber.org\/pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/blogs.funiber.org\/pt\/#\/schema\/logo\/image\/","url":"https:\/\/www.funiber.blog\/pt\/wp-content\/uploads\/2022\/02\/logo-funiber-pt-br-v-dos.svg","contentUrl":"https:\/\/www.funiber.blog\/pt\/wp-content\/uploads\/2022\/02\/logo-funiber-pt-br-v-dos.svg","width":1,"height":1,"caption":"FuniBlogs - FUNIBER"},"image":{"@id":"https:\/\/blogs.funiber.org\/pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/funiber","https:\/\/twitter.com\/FUNIBER","https:\/\/www.instagram.com\/funiber_becas","https:\/\/www.youtube.com\/user\/funiber","https:\/\/www.linkedin.com\/company\/funiber"]},{"@type":"Person","@id":"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/0eae3cfb523a46b015366e49f7c79e8f","name":"Administrador Blogs CT","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/blogs.funiber.org\/pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/097db6469009a1dba4db4c0390a1e929?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/097db6469009a1dba4db4c0390a1e929?s=96&d=mm&r=g","caption":"Administrador Blogs CT"},"url":"https:\/\/www.funiber.blog\/pt\/author\/ct-admin"}]}},"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p7ee1t-wq","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/posts\/2010"}],"collection":[{"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/comments?post=2010"}],"version-history":[{"count":0,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/posts\/2010\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/media?parent=2010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/categories?post=2010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.funiber.blog\/pt\/wp-json\/wp\/v2\/tags?post=2010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}